NasdaqGS - NasdaqGS Real Time Price. Currency in USD
+0.97 (+1.99%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close48.76
Bid0.00 x 900
Ask55.60 x 1800
Day's Range48.49 - 49.76
52 Week Range33.93 - 51.50
Avg. Volume1,789,627
Market Cap11.127B
Beta (3Y Monthly)0.86
PE Ratio (TTM)N/A
EPS (TTM)-4.51
Earnings DateMay 3, 2019
Forward Dividend & Yield0.35 (0.84%)
Ex-Dividend Date2019-03-28
1y Target Est52.70
Trade prices are not sourced from all markets
  • Jerome Dodson Goes 2 for 2 in 1st Quarter
    GuruFocus.com4 days ago

    Jerome Dodson Goes 2 for 2 in 1st Quarter

    Guru invests in Dentsply Sirona, Sysco

  • QIAGEN Drives Molecular Diagnostics Suite With New Test Kit
    Zacks6 days ago

    QIAGEN Drives Molecular Diagnostics Suite With New Test Kit

    QIAGEN (QGEN) introduces the FDA approved companion diagnostic test to help in guiding therapy in any cancer identification.

  • 7 Dental Stocks to Buy That Will Make You Smile
    InvestorPlace7 days ago

    7 Dental Stocks to Buy That Will Make You Smile

    A few years ago I was sitting in the dentist chair for my six-month examination and teeth cleaning. As I stared at the ceiling, I couldn't help notice the name Belmont on the arm of the bright light burning a hole in my retina. I couldn't help myself, asking the dentist if she'd ever invested in a dental-related company? She said she hadn't. "Not even Henry Schein (NASDAQ:HSIC)?", I asked. Nope. That was the end of the investment discussion. Recently, I saw an article that said dental startups such as Candid and Smile Direct Club, which provides systems for mild-to-moderate teeth straightening -- saving you a bundle in the process -- have investors lining up to invest in the private companies. InvestorPlace - Stock Market News, Stock Advice & Trading TipsOf course, that brought me back to that day in the dentist's chair, when I wondered about stocks to buy that will make you smile. * 10 Stocks That Are Screaming Buys Right Now Here are seven names I've identified that will put money in your pockets. Henry Schein (HSIC)Source: Shutterstock If you're a dentist, you've likely got Henry Schein on speed dial. It distributes more than 120,000 branded products and another 180,000 private label products to dentists and medical practitioners. It is the No. 1 global dental distributor and the No. 2 physician and alternate care distributor in the U.S. In fact, 90% of U.S. dental practices are active Schein customers. So, the next time you go to the dentist, be sure to ask how much stuff they buy from the company. It's probably a lot. Things seem to be going smoothly for the Melville, New York, company, yet HSIC is currently trading within 13% of its 52-week low and up less than 5% year-to-date through April 10, one-third the performance of the S&P 500.On three occasions over the past five years, it traded below $55. Within five dollars of doing so a fourth time, HSIC is entering value territory. Fear not. In 2018, Henry Schein's revenues grew by 5.9% year-over-year to $13.2 billion, while its non-GAAP earnings rose 11.4% to $635.3 million, its highest level of sales and profits in its history. Now, exclusively a company dealing with humans after spinning off its animal health business, Henry Schein is ready to take dental to the next level. 3D Systems (DDD)Source: Image via 3D Systems3D Systems (NYSE:DDD) is a 3D printer. Over the past five years as the demand for 3D printing has slowed, so too has the company's revenue and earnings growth. As a result, DDD shares have lost 80% of their value. In 2019, DDD is up more than 7% year-to-date through April 10. However, it lost a great deal of its momentum in March, giving back 23% of its gains on the year. The company's dental segment continues to take a bite out of the competition. It produces dentures, crowns and surgical guides. "There are billions of opportunities here, since virtually anybody could benefit from 3-D printed dental solutions," said CEO Vyomesh Joshi recently. On a non-GAAP basis, 3D Systems went from a $1.7 million loss in 2017 to a $16.5 million gain in 2018 on the strength of a 6% increase in revenue to $688 million. * 10 Dow Jones Stocks Holding the Blue Chip Index Back Trading at 1.8 times revenue, less than half its five-year average price-to-sales ratio, DDD provides investors with an excellent value proposition. Align Technology (ALGN)Source: Shutterstock As dentists go, mine wasn't too pushy about trying the latest and greatest dental product or service, but she sure liked to talk up Invisalign, the $8,000 clear aligner that straightens your teeth. Made by Align Technology (NASDAQ:ALGN), I never took the bait. Now, having moved from Toronto to Halifax over a year ago, and still without a new dentist, I suspect I'll soon be getting the Invisalign sales pitch a second time. Perhaps, startups like Candid are taking a bite out of Align's market share. Given the $4,000 price over 24 months for its teeth alignment product, a good $3,000-$4,000 cheaper than the competition, it's easy to see why. However, I don't think investors should give up on ALGN just yet. As I look at the company's results for 2018, I see a lot of positives.On the top line, revenues grew 34% to $2 billion, a company record, on a 32% increase in Invisalign volume. On the bottom line, net profits were $400.2 million in 2018, 73% higher than a year ago. Forget for a moment that Invisalign didn't exist. Its iTero scanners experienced 68% growth in 2018; iTero's revenues now account for 14% of Align's overall revenue, up 290 basis points from 2017. Trading well off its all-time high of $398.88, investors buying in today, should have significant upside in the months ahead. Dentsply Sirona (XRAY)Source: Shutterstock I first became familiar with Dentsply Sirona (NASDAQ:XRAY) way back in March 2013, more than two years before Dentsply would pay $5.5 billion for Sirona Dental Systems, a company I liked because of its diversified revenue streams. "Sirona's revenue diversification is what makes it such a good company. It generates business from four operating segments: Dental CAD/CAM Systems, Imaging Systems, Treatment Centers, and Instruments," I wrote March 20, 2013. "Its CAD/CAM and Imaging Systems accounted for 70% of its overall revenue in the first quarter ended December 2012."If you took my advice and bought 100 shares of Sirona at the Q2 2013 high of $73.98, today you'd have $9,158, a 24% return. But over three years, it's seen a mediocre 5% return. So, do I still think XRAY is worth holding for the long haul?I do. Here's why.Like most acquisitions, the tie-up didn't go nearly as smoothly as hoped. As a result, the company was forced to implement a turnaround plan that will simplify its business. Where have I heard that before?Anyway, when you bring together two reasonably large businesses, you often lose focus on parts of it and those units suffer. So, it's exiting these businesses and cutting staffing by as much as 8%. By fiscal 2020, analysts expect it to earn $2.64 a share, its best earnings performance since 2016. * The 7 Best Long-Term Stocks for 2019 And Beyond It has had a good run in 2019, up 36% year-to-date. I'd be patient and try to buy on weakness in the mid-$40s. Patterson Companies (PDCO)Source: Shutterstock A little over two years ago, Globe and Mail business reporter Scott Barlow highlighted 12 healthcare stocks that had stable cash flow. He argued that businesses such as Patterson Companies (NASDAQ:PDCO), a distributor of dental and animal health products, would make you rich over the long haul because of this critical attribute. Since the article, PDCO stock has lost approximately half its value. Ouch.However, in the nine months ended Jan. 27, 2019, Patterson's operating cash flow increased 91% to $76.3 million. After subtracting $33.9 million in capital expenditures, it generated free cash flow of $42.4 million or 77% of its net income. On the top line, revenues in the first three quarters of fiscal 2019 barely budged, up 1.8% to $4.14 billion. On the bottom line GAAP basis, its net income fell 69% to $55.2 million. On an adjusted basis, earnings fell 25% to $95.9 million. While this article is about dental businesses, Patterson's animal health business (58% of revenue) continues to provide PDCO with diversified revenue streams that will protect it when the economy turns south because a lot of pet owners won't scrimp on their companion animal's wellbeing. Yielding 4.8% at the moment, it has plenty of free cash flow to keep paying its juicy dividend. If you're an income investor, PDCO is an excellent stock to own before the company's restructuring takes hold. Get paid to wait. Procter & Gamble (PG)Source: Mike Mozart via Flickr (Modified)My old dentist's dental technician recommended that I buy an Oral-B electric toothbrush because it does a better job of brushing your teeth without overdoing it, thus hurting your gums. She was right. Originally invented in 1950 by California periodontist Dr. Robert Hutson, he sold the company to Cooper Laboratories, who in turn sold it to Gillette in 1984 for $188.5 million. The rest, as they say, is history. On April 9, Oral-B's owner, Procter & Gamble (NYSE:PG), raised its quarterly dividend by 4% to 74.59 cents a share, an annualized rate of $2.98, yielding 2.8% despite a 37% gain over the past 52 weeks. This is P&G's 63rd consecutive year increasing its dividend. Oral-B and the rest of its oral care brands generated 9% of P&Gs revenue in the second quarter. Part of the healthcare segment, sales and earnings were both up slightly in the first quarter, delivering solid if not spectacular results. * The 10 Fastest-Growing Stocks to Invest In Right Now Consider Oral-B the company's slow-growth business. Overall, however, Procter & Gamble is doing just fine. Church & Dwight (CHD) Source: slgckgc via Flickr (Modified)Church & Dwight (NYSE:CHD) is a smaller version of P&G. But make no mistake, it competes with the best of them. As far as dental care goes, it has Arm & Hammer, AIM, Close-Up and Pepsodent toothpaste. Other brands include Orajel and Waterpik. The company has become adept at making smaller acquisitions and then growing those businesses over time. Most recently, it announced it had acquired two hair removal brands, Flawless and Finishing Touch, for $475 million and a further $425 million in potential earnouts. The two brands add $180 million in annual revenue and $55 million in EBITDA.The owners of Flawless would have been wise to ask for stock instead of cash because over the past decade, CHD stock has delivered an annualized total return of 19.4%, almost double P&G.As stocks go, CHD is a perfect 10. I urge you to check it out. At the time of this writing, Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Internet Stocks to Watch * 7 AI Stocks to Watch with Strong Long-Term Narratives * 10 Dow Jones Stocks Holding the Blue Chip Index Back Compare Brokers The post 7 Dental Stocks to Buy That Will Make You Smile appeared first on InvestorPlace.

  • Here's Why You Should Bet on Cooper Companies (COO) Stock Now
    Zacks11 days ago

    Here's Why You Should Bet on Cooper Companies (COO) Stock Now

    Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across its segments and prudent acquisitions.

  • GlobeNewswire13 days ago

    Dentsply Sirona to Host First Quarter 2019 Conference Call on May 3rd

    YORK, Pa., April 09, 2019 -- DENTSPLY SIRONA Inc. (NASDAQ:XRAY), The Dental Solutions Company™, today announced that the Company will host an investor conference call and live.

  • Did Hedge Funds Drop The Ball On DENTSPLY SIRONA Inc. (XRAY) ?
    Insider Monkey13 days ago

    Did Hedge Funds Drop The Ball On DENTSPLY SIRONA Inc. (XRAY) ?

    Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of December. At Insider Monkey, we follow nearly 750 active hedge funds and notable investors and by analyzing their 13F filings, we can determine the stocks that they are […]

  • Why Shares in Dentsply Sirona Soared Nearly 19% in March
    Motley Fool13 days ago

    Why Shares in Dentsply Sirona Soared Nearly 19% in March

    Investors warmed to the company's turnaround plan following a good set of earnings.

  • Markit13 days ago

    See what the IHS Markit Score report has to say about DENTSPLY SIRONA Inc.

    DENTSPLY SIRONA Inc NASDAQ/NGS:XRAYView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is low for XRAY with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, growth of ETFs holding XRAY is favorable, with net inflows of $28.19 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • BD Introduces New Product to Reduce the Risk of Sepsis
    Zacks13 days ago

    BD Introduces New Product to Reduce the Risk of Sepsis

    BD introduces new FDA cleared product to lower the risk of sepsis and combat platelet contamination.

  • Barrons.com14 days ago

    5 Stocks That Have Left the Market in the Dust Recently

    The stock market has gained a solid 3.9% since Feb. 28—but the market’s best-performing stocks have made multiples of that, helped by strong earnings reports and promising product pipelines.

  • Here's Why You Should Invest in DENTSPLY (XRAY) Stock Now
    Zacks17 days ago

    Here's Why You Should Invest in DENTSPLY (XRAY) Stock Now

    Strong prospects in emerging markets provide DENTSPLY (XRAY) a competitive edge in the MedTech space.

  • XRAY vs. CNMD: Which Stock Is the Better Value Option?
    Zacks17 days ago

    XRAY vs. CNMD: Which Stock Is the Better Value Option?

    XRAY vs. CNMD: Which Stock Is the Better Value Option?

  • Dentsply (XRAY) Up 18.8% Since Last Earnings Report: Can It Continue?
    Zacks22 days ago

    Dentsply (XRAY) Up 18.8% Since Last Earnings Report: Can It Continue?

    Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Top Ranked Momentum Stocks to Buy for March 21st
    Zackslast month

    Top Ranked Momentum Stocks to Buy for March 21st

    Top Ranked Momentum Stocks to Buy for March 21st

  • XRAY vs. CNMD: Which Stock Should Value Investors Buy Now?
    Zackslast month

    XRAY vs. CNMD: Which Stock Should Value Investors Buy Now?

    XRAY vs. CNMD: Which Stock Is the Better Value Option?

  • Benzingalast month

    BofA Expects Dentsply Sirona's Performance To Improve With New Product Ramp, Cost-Cutting

    Dentsply Sirona Inc (NASDAQ: XRAY ) is in the midst of a major transition. Potential cost savings should support EPS, and the dental equipment supplier could achieve more consistent revenue growth due ...

  • GuruFocus.comlast month

    Dentsply Sirona Inc (XRAY) Files 10-K for the Fiscal Year Ended on December 31, 2018

    Dentsply Sirona Inc is a designer, developer, manufacturer and marketer of consumable dental products for the professional dental market. The dividend yield of Dentsply Sirona Inc stocks is 0.73%. Warning! GuruFocus has detected 2 Warning Signs with XRAY.

  • Will DENTSPLY SIRONA Continue to Surge Higher?
    Zackslast month

    Will DENTSPLY SIRONA Continue to Surge Higher?

    As of late, it has definitely been a great time to be an investor in DENTSPLY SIRONA.

  • DENTSPLY's (XRAY) Preliminary Q4 Results Cheer Investors
    Zacks2 months ago

    DENTSPLY's (XRAY) Preliminary Q4 Results Cheer Investors

    DENTSPLY (XRAY) expects to see solid performance in Europe and the rest of the world.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of XRAY earnings conference call or presentation 1-Mar-19 1:30pm GMT

    Q4 2018 Dentsply Sirona Inc Earnings Call

  • Associated Press2 months ago

    Gap and Foot Locker jump while Tesla and Kroger tumble

    Stocks that moved substantially or traded heavily on Friday: Gap Inc., up $4.11 to $29.51 The retailer behind its namesake and Banana Republic brands will spin off Old Navy into a publicly traded company. ...

  • Investing.com2 months ago

    Stocks - S&P Closes Above 2,800 for First Time Since November

    Investing.com - The S&P; 500 racked up solid gains Friday to close above a key level, shrugging off data pointing to slowing U.S. economic and global growth as hopes of a U.S.-China trade deal kept risk appetite alive.